Table 2.
Parameters | UTX Expression | E-Cadherin Expression | |||||
---|---|---|---|---|---|---|---|
Low | High | p Value | Low | High | p Value | ||
Age (years) | <55 | 29 | 23 | 0.58 | 25 | 27 | 0.85 |
≥55 | 33 | 21 | 25 | 29 | |||
Primary tumor location | U + M | 30 | 25 | 0.39 | 22 | 33 | 0.13 |
L | 32 | 19 | 28 | 23 | |||
T classification | T1 + T2 | 38 | 32 | 0.22 | 26 | 44 | 0.004 * |
T3 + T4 | 24 | 12 | 24 | 12 | |||
N classification | N0 | 37 | 33 | 0.10 | 25 | 45 | 0.001 * |
N1 + 2 + 3 | 25 | 11 | 25 | 11 | |||
7th AJCC Stage | I | 20 | 18 | 0.36 | 12 | 26 | 0.016 * |
II + III + IV | 42 | 26 | 38 | 30 | |||
Histological grading | Grade 1 + 2 | 44 | 36 | 0.20 | 34 | 46 | 0.091 |
Grade 3 | 18 | 8 | 16 | 10 | |||
Surgical margin | Negative | 50 | 41 | 0.068 | 40 | 51 | 0.10 |
Positive | 12 | 3 | 10 | 5 | |||
E-cadherin expression | Low | 36 | 14 | 0.008 * | - | - | - |
High | 26 | 30 | - | - | - |
AJCC, American Joint Committee on Cancer. * Statistically significant.